Ranking CG Score 1/ CG Score AGM Level 2/ AGM Score Thai-CAC 3/ Thai CAC 3/ n/a Thailand Sustainability Investment 4/ Thailand Sustainability Investment n/a Ranking by Industry Business 4/ Business The
3/ Thai CAC 3/ Declared Thailand Sustainability Investment 4/ Thailand Sustainability Investment n/a Ranking by Industry Business 4/ Business The Company engages in the business of manufacturing and
Assets by Subsidiary of DOD Biotech Public Company Limited for the Purchase and Acceptance of Transfer of the Entire Business of BGP Spectrum Power Co., Ltd., and Establishment of Subsidiary, Classified as
overall sales volume, the Company and its subsidiaries brought 1.6% growth of Gross profit margin versus 2017 by the strong contribution of Epicerol® business. 2. In 2018, distribution costs, administrative
% respectively, which decreased by 4.0%. The decrease was primarily due to the more effective internal control system of The Company. Financing Costs The Company and its subsidiary ‘s financing costs in relation
separately from revenue from sales (financing component separation) at the amount of Baht 22.47 million and then gradually recognized as revenue for each period until maturity date. 3. Selling and
at the same rate as the financing cost of the Lender. Therefore, it is reasonable to increase the efficiency of capital management and reduce financial costs; including the risk of non-payment
2nd Quarter Changes 2019 2018 Amount % Revenue from expressway business 2,521 2,477 44 1.8 Revenue from rail business 1,162 1,162 - - Revenue from commercial development business 179 160 19 11.9
million in 3Q17 and 9M17, respectively. The main drivers were attributable to a decrease in room revenue due to three hotel renovations and an increase in administrative expenses to support business